Volition advances epigenetics for diagnosis and monitoring of life-altering diseases.
Its patented technologies use chromosomal structures, including nucleosomes and transcription factors, as biomarkers in cancer and other diseases. Volition is headquartered in Henderson, Nevada, with locations in Belgium, California, Singapore and the UK.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Its nucleosome quantification technology is used in veterinary cancer applications.
Its tests detect characteristic changes from early disease stages, supporting early detection and monitoring of disease progression and patient response to treatment.
Source: LinkedIn company description · Retrieved October 13, 2026
Volition developed Capture-PCR™, a liquid biopsy method for cancer detection in a routine blood test.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 19, 2026 and October 10, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.